Laia Matas

513 total citations
19 papers, 185 citations indexed

About

Laia Matas is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, Laia Matas has authored 19 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Infectious Diseases. Recurrent topics in Laia Matas's work include COVID-19 Clinical Research Studies (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Heart Rate Variability and Autonomic Control (3 papers). Laia Matas is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Heart Rate Variability and Autonomic Control (3 papers). Laia Matas collaborates with scholars based in Spain. Laia Matas's co-authors include Beatriz Lucas, Noé Garín, Ana Rodrigo‐Troyano, F. Baigorri, Jordi Rello, Antonio Artigas, Jordi Vallés, Rafael Fernández, L. Blanch and Eva Balada and has published in prestigious journals such as Scientific Reports, Medicine and Atherosclerosis.

In The Last Decade

Laia Matas

16 papers receiving 180 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laia Matas Spain 6 61 48 47 32 25 19 185
Leire Leache Spain 10 30 0.5× 35 0.7× 11 0.2× 18 0.6× 43 1.7× 40 278
Ghazwa B. Korayem Saudi Arabia 8 35 0.6× 38 0.8× 11 0.2× 9 0.3× 50 2.0× 47 229
Vinay Vaidya United States 7 26 0.4× 42 0.9× 16 0.3× 19 0.6× 7 0.3× 20 243
André Bonnici Canada 6 65 1.1× 39 0.8× 11 0.2× 9 0.3× 14 0.6× 16 198
Mahuya Bhattacharyya India 7 15 0.2× 63 1.3× 22 0.5× 22 0.7× 7 0.3× 18 134
Rebecca L. Attridge United States 9 23 0.4× 42 0.9× 41 0.9× 24 0.8× 17 0.7× 26 268
Raymond Robbins Australia 10 19 0.3× 51 1.1× 53 1.1× 28 0.9× 11 0.4× 25 286
Krishnaswamy Sundararajan Australia 7 20 0.3× 70 1.5× 39 0.8× 25 0.8× 18 0.7× 33 294
Sérgio Henrique Loss Brazil 10 20 0.3× 76 1.6× 103 2.2× 132 4.1× 23 0.9× 27 375
Khaled Mohammed Al‐Sayaghi Saudi Arabia 8 9 0.1× 22 0.5× 59 1.3× 25 0.8× 18 0.7× 41 172

Countries citing papers authored by Laia Matas

Since Specialization
Citations

This map shows the geographic impact of Laia Matas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laia Matas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laia Matas more than expected).

Fields of papers citing papers by Laia Matas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laia Matas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laia Matas. The network helps show where Laia Matas may publish in the future.

Co-authorship network of co-authors of Laia Matas

This figure shows the co-authorship network connecting the top 25 collaborators of Laia Matas. A scholar is included among the top collaborators of Laia Matas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laia Matas. Laia Matas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Castellví, I., Diego Castillo, Hèctor Corominas, et al.. (2022). Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study. Frontiers in Medicine. 9. 973918–973918. 7 indexed citations
3.
Corominas, Hèctor, I. Castellví, Cèsar Díaz‐Torné, et al.. (2021). Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2. Medicine. 100(19). e25923–e25923. 3 indexed citations
4.
Corominas, Hèctor, I. Castellví, Virginia Pomar, et al.. (2020). Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort. Clinical Immunology. 223. 108631–108631. 14 indexed citations
5.
Matas, Laia, et al.. (2018). Acute mediastinitis as a rare complication of an infectious mononucleosis. Enfermedades infecciosas y microbiologia clinica (English ed ). 36(9). 601–602. 2 indexed citations
6.
Feliu, Ariadna, et al.. (2018). BENEFITS OF MINDFULNESS MEDITATION IN REDUCING BLOOD PRESSURE AND STRESS IN PATIENTS WITH ARTERIAL HYPERTENSION. Journal of Hypertension. 36(Supplement 1). e294–e295. 5 indexed citations
7.
Plana, Núria, Anna Arnau, Laia Matas, et al.. (2018). Causes of failure to achieve the low density lipoprotein cholesterol therapeutic target in patients with high and very high vascular risk controlled in Lipid and Vascular Risk Units. EROMOT study. Clínica e Investigación en Arteriosclerosis (English Edition). 30(1). 1–9. 3 indexed citations
9.
Matas, Laia, et al.. (2016). Resistant hypertension and no organ damage: A new case of Munchausen syndrome. Medicina Clínica (English Edition). 146(9). e51–e52.
10.
Martín‐Campos, Jesús M., Josep Julve, Núria Plana, et al.. (2016). Low-density lipoprotein gene score to identify polygenic forms of familial hypercholesterolemia in a Spanish population. Atherosclerosis. 252. e33–e34. 2 indexed citations
11.
Sole, María José Del, et al.. (2015). Differences in the reduction of blood pressure according to drug administration at activity hours or rest hours. Medicina Clínica (English Edition). 144(2). 51–54. 1 indexed citations
12.
Arroyo, Juan Antonio, et al.. (2014). Diferencias en la reducción de la presión arterial en función de la toma de la medicación en horario diurno o nocturno. Medicina Clínica. 144(2). 51–54. 2 indexed citations
13.
Ruiz, Virginia, María A. Barnadas, Laia Matas, Sílvia Bagué, & Agustı́n Alomar. (2011). Nódulos cutáneos similares a eritema nodoso como manifestación de criptococosis diseminada. Actas Dermo-Sifiliográficas. 102(3). 221–223.
14.
Balada, Eva, et al.. (2002). Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population. Medicina Clínica. 119(5). 161–165. 9 indexed citations
15.
Sancho, Juan‐Manuel, Josep‐María Ribera, Laia Matas, & Evarist Feliú. (1998). [Fusarium solani infection in a hematology unit. Study of 2 cases and 2 isolations].. PubMed. 111(8). 319–319. 2 indexed citations
16.
Vallés, Jordi, Jordi Rello, Laia Matas, et al.. (1996). Impact of using an indwelling introducer on diagnosis of Swan-Ganz pulmonary artery catheter colonization. European Journal of Clinical Microbiology & Infectious Diseases. 15(1). 71–75. 6 indexed citations
17.
Matas, Laia, et al.. (1995). [Bacteremia in 13 general hospitals of the province of Barcelona. Prospective study of 1,674 episodes. Group of Microbiologists of the County Hospitals of Catalonia].. PubMed. 13(6). 345–55. 4 indexed citations
18.
Vallés, Jordi, Jordi Rello, Rafael Fernández, et al.. (1994). Role of bronchoalveolar lavage in mechanically ventilated patients with suspected pneumonia. European Journal of Clinical Microbiology & Infectious Diseases. 13(7). 549–558. 44 indexed citations
19.
Ausina, V., et al.. (1985). [Nocardiosis in immunosuppressed patients].. PubMed. 84(3). 90–5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026